Biomea Fusion is trading 7.84% down at $0.77 on October 20, 2026, with no clear company-specific announcement identified to explain the decline.
- The latest company news found was October 13 Phase 1 BMF-650 results; reports noted shares fell after that release, but it does not establish the cause of this session’s move.
- XBI is up 2.10%, opposite the stock’s direction.
- Broader market indices are also reported higher, so the available evidence does not confirm a sector- or market-driven cause.